Belite Bio
BLTE
18 hedge funds and large institutions have $4.51M invested in Belite Bio in 2025 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 6 increasing their positions, 5 reducing their positions, and 6 closing their positions.
20% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 5
0% more funds holding
Funds holding: 18 → 18 (0)
0% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 6
0.22% less ownership
Funds ownership: 0.46% → 0.24% (-0.22%)
55% less capital invested
Capital invested by funds: $9.91M → $4.51M (-$5.4M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Marshall Wace
London,
United Kingdom
|
+$579K |
| 2 |
Renaissance Technologies
New York
|
+$262K |
| 3 |
BNP Paribas Financial Markets
Paris,
France
|
+$201K |
| 4 |
CSS
Cubist Systematic Strategies
Stamford,
Connecticut
|
+$175K |
| 5 |
EWA
EverSource Wealth Advisors
Birmingham,
Alabama
|
+$156K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Alyeska Investment Group
Chicago,
Illinois
|
-$5.54M |
| 2 |
HF
HRT Financial
New York
|
-$272K |
| 3 |
Bank of America
Charlotte,
North Carolina
|
-$263K |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
-$204K |
| 5 |
RhumbLine Advisers
Boston,
Massachusetts
|
-$95K |
BLTE Hedge Fund Activity: Q2 2025 in Review
18 of the 7,614 institutional investors tracked by Wall St. Rank reported a position in Belite Bio (BLTE) for Q2 2025, worth a combined $4.51M — down 55% from $9.91M a quarter earlier.
Fund positioning in BLTE was balanced in Q2 2025: 6 funds opened new positions, 6 closed out, 6 added to existing stakes and 5 trimmed.
The largest buyer was Marshall Wace, opening a new position worth an estimated $579K. The largest seller was Alyeska Investment Group, exiting entirely with an estimated $5.54M sold.
- 18 institutional investors held Belite Bio (BLTE) as of Q2 2025, unchanged from Q1 2025.
- Funds reported $4.51M of Belite Bio stock for Q2 2025, down 55% quarter-over-quarter.
- 6 funds opened new Belite Bio positions in Q2 2025 and 6 closed out, a net change of 0 holders.
- The largest Belite Bio buyer in Q2 2025 was Marshall Wace, an estimated $579K added.
- The largest Belite Bio seller in Q2 2025 was Alyeska Investment Group, an estimated $5.54M sold.
Based on aggregated 13F filings for Q2 2025.